US 10370367
IRAK inhibitors and method for making and using
granted A61PA61P29/00
Quick answer
US patent 10370367 (IRAK inhibitors and method for making and using) held by Rigel Pharmaceuticals, Inc. expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P29/00